PMA P850048S016

Device
ACCESS(R) HYBRITECH PSA ASSAY
Applicant
Beckman Coulter, Inc.
PMA number
P850048
Supplement
S016
Product code
LTJ
Decision date
2000-02-24
Classification
Prostate-specific Antigen (psa) For Management Of Prostate Cancers
Generic name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Approval order statement
Approval for addition of the Access Hybritech PSA Assay on the Access Immunoassay analyzer to other approved instrument platforms.

Current openFDA PMA Record#

Device
ACCESS(R) HYBRITECH PSA ASSAY
Applicant
Beckman Coulter, Inc.
PMA number
P850048
Supplement
S016
Product code
LTJ
Generic name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Decision date
2000-02-24
Decision code
APPR
Date received
1999-10-18
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for addition of the Access Hybritech PSA Assay on the Access Immunoassay analyzer to other approved instrument platforms.